S’pore’s digital health platform Speedoc raises US$28mil funding

S’pore’s digital health platform Speedoc raises US$28mil funding

New investors Bertelsmann Investments, Shinhan Venture Investment and Mars Growth participated in the pre-Series B round.

Speedoc operates as a virtual clinic and hospital care provider, combining on-site and digital services. (Facebook pic/Speedoc)
CEBU:
Singapore-based digital health platform Speedoc said in a statement today that it has raised US$28 million in a pre-Series B round of funding.

New investors Bertelsmann Investments, Shinhan Venture Investment and Mars Growth participated in the round, as did return backer Vertex Ventures Southeast Asia and India. DealStreetAsia earlier reported that the company had raised at least US$13 million, citing regulatory filings.

The digital health platform closed a US$5 million Series A round in December 2020, which was led by Vertex. Other investors that participated included Decacorn Capital and Global Grand Leisure.

In 2019, the startup raised US$1.8 million in a seed round from Asian family offices such as Footprints Investments and Medic Everlasting Discovery.

Speedoc was founded in 2017 by Duke-NUS Medical School graduate Dr Shravan Verma. It operates as a virtual clinic and hospital care provider, combining on-site and digital services to provide care for patients in their homes. Services include house-call doctors, nurses, medication delivery, telemedicine, remote diagnosis and health monitoring.

“Our end-to-end care system connects qualified medical professionals to patients, and delivers different types of care to cater to different types of conditions,” the company says on its website.

Speedoc earlier said it was looking to expand further in Southeast Asia beyond its existing presence in Singapore, Kuala Lumpur and Johor Bahru in Malaysia.

Digital health startups in Southeast Asia have been attracting increased investor interest. In August, Vietnam-based health care and insurance platform Medici raised US$8.5 million in a Series A round led by Singapore-based venture capital company Jungle Ventures. Singapore health tech unicorn Biofourmis raised US$20 million from Intel Capital Corporation in July.

Stay current - Follow FMT on WhatsApp, Google news and Telegram

Subscribe to our newsletter and get news delivered to your mailbox.